Sofinnova Narrows Focus with Fund VIII

Life sciences firm wraps up latest effort with $440M

1 November 2011•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.